Dostarlimab an Inhibitor of PD-1/PD-L1: A New Paradigm for the Treatment of Cancer
Article in Medicina (November 2022)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Article in Medicina (November 2022)
Article in ACS Central Science (August 2022)
Article in BMC Cancer (March 2022)